BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for X4 Pharmaceuticals, Inc. (XFOR)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for X4 Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-13
5:51 pm
Sale		 2022-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 BIOTECHNOLOGY VALUE FUND L P 2,258,400
1.900%		 -769,272decrease
(-25.41%)		 Filing
2022-02-14
1:02 pm
Purchase		 2021-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 BIOTECHNOLOGY VALUE FUND L P 3,027,672
9.990%		 1,308,056increase
(+76.07%)		 Filing
2021-02-12
8:57 pm
Purchase		 2020-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 BIOTECHNOLOGY VALUE FUND L P 1,719,616
9.990%		 59,141increase
(+3.56%)		 Filing